Syndax Pharmaceuticals Inc (SNDX)
Cash & Short-Term Investments
$547.86M
Quarterly · Period ending: · USD
SNDX Cash & Short-Term Investments
Latest reported$547.86Mperiod ending
Latest reported$547.86Mperiod ending
SNDX Quarterly Cash & Short-Term Investments ($628.00 → $547.86M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
SNDX cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 547,860,000 | |
| 352,064,000 | |
| 394,070,000 | |
| 454,174,000 | |
| 468,706,000 | |
| 516,313,000 | |
| 582,913,000 | |
| 389,607,000 | |
| 425,097,000 | |
| 434,578,000 | |
| 577,583,000 | |
| 363,556,000 | |
| 406,024,000 | |
| 432,393,000 | |
| 484,397,000 | |
| 350,708,000 | |
| 376,678,000 | |
| 410,909,000 | |
| 446,830,000 | |
| 229,714,000 | |
| 253,132,000 | |
| 271,335,000 | |
| 293,065,000 | |
| 170,159,000 | |
| 186,753,000 | |
| 99,005,000 | |
| 59,775,000 | |
| 72,238,000 | |
| 80,520,000 | |
| 92,742,000 | |
| 80,911,000 | |
| 89,599,000 | |
| 98,385,000 | |
| 113,223,000 | |
| 133,220,000 | |
| 120,594,000 | |
| 129,955,000 | |
| 92,785,000 | |
| 105,330,000 | |
| 115,567,000 | |
| 125,457,000 | |
| 133,670,000 | |
| 87,294,000 | |
| 100,461,000 | |
| 12,208,000 | |
| 12,208,000 | |
| 11,691,000 | |
| 5,010,000 | |
| 9,497,000 | |
| 14,264,000 | |
| 5,069,000 | |
| 628 | |
| 628 |